Coombes RC, Tovey H, Kilburn L, et al. A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial). SABCS 2017, GS3-03.
Anti-PD-1 bij niet-resectabel desmoplastisch melanoom
dec 2025 | Dermato-oncologie, Immuuntherapie